Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is concerned with the social legitimacy of internal market law. What does social legitimacy entail within the multi-level 'embedded liberalism' construction of the internal market? How can the objectives of the internal market that focus on economic rights and a commitment to social diversity both be pursued without one necessarily trumping the other? These questions continue to challenge the very core of European integration. How can the diversity of Member States' 'social systems' and the varying normative infrastructure of their economies be sustainably accommodated within the internal market? This book seeks to contribute to these questions by discussing what has come to be known as the argument from transnational effects and the development of an adjudicative model for the European Court of Justice that can be termed 'socially responsive'. Drawing on the historical insights of Karl Polanyi it argues that the internal market can only be held to be socially legitimate where it supports the requirement for further market integration while still responding to social practices and values within the member states. The book presents in-depth studies of the case law of the Court in the areas of EU free movement, competition and state aid law. In so doing, this important new study aims to provide the language and tools for assessing social legitimacy in the internal market

Law --- Social aspects --- Droit --- Aspect social --- Europe --- European law --- Economic law --- European Union --- European Union countries. --- Social aspects. --- Law - Social aspects - European Union countries

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control. The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed. Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law"--

Prescription pricing --- Drugs --- Pharmacy --- Law and legislation --- Law and legislation --- Law and legislation

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

European Competition Law Handbook provides a comprehensive digest of Commission decisions and competition cases before the EU and national courts, conveniently cross-referenced by subject matter, for the swift location of the full list of relevant case-law, regulations and notices.